{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:43:00Z","timestamp":1777956180113,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA054177"],"award-info":[{"award-number":["DA054177"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA045011"],"award-info":[{"award-number":["DA045011"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA011792"],"award-info":[{"award-number":["DA011792"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA043204"],"award-info":[{"award-number":["DA043204"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpet.2025.103657","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:43:23Z","timestamp":1752680603000},"page":"103657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using a rich-lean transition procedure to evaluate putative antianxiety medications"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4644-5788","authenticated-orcid":false,"given":"Forrest","family":"Toegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-8398","authenticated-orcid":false,"given":"Cory","family":"Toegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josh A.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Austin","family":"Zamarripa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-9887","authenticated-orcid":false,"given":"William S.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-0926","authenticated-orcid":false,"given":"Sally L.","family":"Huskinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpet.2025.103657_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpet.2025.103657_bib2","first-page":"1","article-title":"Symptoms of generalized anxiety disorder among adults: United States, 2019","volume":"378","author":"Terlizzi","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals\u2013implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology"},{"issue":"34","key":"10.1016\/j.jpet.2025.103657_bib4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","article-title":"Trends in nonfatal and fatal overdoses involving benzodiazepines\u201438 states and the District of Columbia, 2019\u20132020","volume":"70","author":"Liu","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.jpet.2025.103657_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABAA receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.jpet.2025.103657_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype-and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"A","key":"10.1016\/j.jpet.2025.103657_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABAA receptor: positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.jpet.2025.103657_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.jpet.2025.103657_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.31887\/DCNS.2015.17.3\/mbourin","article-title":"Animal models for screening anxiolytic-like drugs: a perspective","volume":"17","author":"Bourin","year":"2015","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.jpet.2025.103657_bib12","first-page":"327","article-title":"Effects of behaviorally active drugs in a conflict-punishment procedure in rats","volume":"vol. 5","author":"Cook","year":"1973"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002130050826","article-title":"Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans","volume":"141","author":"Kleven","year":"1999","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-005-0228-8","article-title":"Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABA A receptors","volume":"184","author":"Rowlett","year":"2006","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.jpet.2025.103657_bib15","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1007\/s00213-019-05286-0","article-title":"Self-administration of benzodiazepine and cocaine combinations by male and female rhesus monkeys in a choice procedure: role of \u03b11 subunit\u2013containing GABA A receptors","volume":"236","author":"Huskinson","year":"2019","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00492364","article-title":"The effects of electric shock on responding maintained by cocaine injections in a choice procedure in the rhesus monkey","volume":"53","author":"Johanson","year":"1977","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0091-3057(81)90413-5","article-title":"The effects of electric shock on responding maintained by cocaine in rhesus monkeys","volume":"14","author":"Bergman","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1901\/jeab.1992.57-33","article-title":"Fixed-ratio pausing: joint effects of past reinforcer magnitude and stimuli correlated with upcoming magnitude","volume":"57","author":"Perone","year":"1992","journal-title":"J Exp Anal Behav"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jaba.283","article-title":"A translational evaluation of transitions","volume":"49","author":"Jessel","year":"2016","journal-title":"J Appl Behav Anal"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/FBP.0b013e3280d48073","article-title":"Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses","volume":"18","author":"Galuska","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jpet.2025.103657_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.beproc.2023.104858","article-title":"Rich-lean transitions produced by stimuli associated with accurate and inaccurate responding by pigeons","volume":"207","author":"Toegel","year":"2023","journal-title":"Behav Processes"},{"key":"10.1016\/j.jpet.2025.103657_bib22","series-title":"Emotional processing theory: an update","author":"Foa","year":"2006"},{"key":"10.1016\/j.jpet.2025.103657_bib23","first-page":"12","article-title":"Aggression and anxiety: social context and neurobiological links","volume":"4","author":"Neumann","year":"2010","journal-title":"Front Behav Neurosci"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib24","first-page":"500","article-title":"Transitions from rich-to-lean schedules increase attack in a laboratory model of social aggression in pigeons: I. Fixed-ratio schedules","volume":"45","author":"Williams","year":"2019","journal-title":"Rev Mex An\u00e1l Conducta"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jeab.74","article-title":"Behavioral functions of stimuli signaling transitions across rich and lean schedules of reinforcement","volume":"101","author":"Everly","year":"2014","journal-title":"J Exp Anal Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jeab.236","article-title":"Escape from rich-to-lean transitions: stimulus change and timeout","volume":"107","author":"Retzlaff","year":"2017","journal-title":"J Exp Anal Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jeab.540","article-title":"Assessing functions of stimuli associated with rich-to-lean transitions using a choice procedure","volume":"112","author":"Langford","year":"2019","journal-title":"J Exp Anal Behav"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0269881109354928","article-title":"Preclinical and clinical pharmacology of TPA023B, a GABAA receptor \u03b12\/\u03b13 subtype-selective partial agonist","volume":"25","author":"Atack","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103657_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00429273","article-title":"The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat","volume":"1","author":"Geller","year":"1960","journal-title":"Psychopharmacologia"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0091-3057(98)00191-9","article-title":"The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine","volume":"62","author":"Lin","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jeab.242","article-title":"Effects of shifts in food reinforcement context on rats\u2019 consumption of concurrently available water or sucrose solution","volume":"107","author":"Galuska","year":"2017","journal-title":"J Exp Anal Behav"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0269881119882803","article-title":"Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for \u03b13 subunit-containing GABAA receptors","volume":"34","author":"Meng","year":"2020","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1037\/pha0000547","article-title":"Choice between food and cocaine reinforcers under fixed and variable schedules in female and male rhesus monkeys","volume":"31","author":"Zamarripa","year":"2023","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.jpet.2025.103657_bib56","doi-asserted-by":"crossref","first-page":"110953","DOI":"10.1016\/j.drugalcdep.2023.110953","article-title":"Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeys","volume":"252","author":"Huskinson","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(02)00331-9","article-title":"Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and \u00df-funaltrexamine","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103657_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pbb.2015.12.001","article-title":"Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys","volume":"141","author":"Banks","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jeab.730","article-title":"Effects of advance notice on transition-related pausing in pigeons","volume":"117","author":"Toegel","year":"2022","journal-title":"J Exp Anal Behav"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF03394985","article-title":"Inhibition by reinforcement: effects of reinforcer magnitude and timeout on fixed-ratio pausing","volume":"37","author":"Perone","year":"1987","journal-title":"Psychol Rec"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jeab.703","article-title":"Effects of chlordiazepoxide on pausing during rich-to-lean transitions","volume":"116","author":"Langford","year":"2021","journal-title":"J Exp Anal Behav"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib38","first-page":"73","article-title":"\u201cBehavior-releasing\u201d effects of drugs: anti-punishment and anti-conflict procedures","volume":"32","author":"Rasmussen","year":"2006","journal-title":"Rev Mex An\u00e1l Conducta"},{"issue":"4","key":"10.1016\/j.jpet.2025.103657_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00213-005-0119-z","article-title":"A comparison of chlordiazepoxide, bretazenil, L838, 417 and zolpidem in a validated mouse Vogel conflict test","volume":"182","author":"Mathiasen","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpet.2025.103657_bib40","series-title":"GABA and Sleep: Molecular, Functional and Clinical Aspects","first-page":"25","article-title":"Development of subtype-selective GABAA receptor compounds for the treatment of anxiety, sleep disorders and epilepsy","author":"Atack","year":"2010"},{"issue":"6","key":"10.1016\/j.jpet.2025.103657_bib41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/npp.2012.265","article-title":"Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam-but not cocaine-experienced rhesus monkeys","volume":"38","author":"Shinday","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib42","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7282","key":"10.1016\/j.jpet.2025.103657_bib43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.118.249250","article-title":"Evidence that sedative effects of benzodiazepines involve unexpected GABAA receptor subtypes: quantitative observation studies in rhesus monkeys","volume":"366","author":"Duke","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.jpet.2025.103657_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/02698811241286760","article-title":"Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys","volume":"38","author":"Sharmin","year":"2024","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103657_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbr.2009.03.030","article-title":"Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors","volume":"202","author":"Rezayof","year":"2009","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.jpet.2025.103657_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000070457","article-title":"Anxiolytic effects of acute morphine can be modulated by nitric oxide systems","volume":"68","author":"Shin","year":"2003","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103657_bib48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1819.2010.02143.x","article-title":"Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats","volume":"64","author":"Solati","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00432367","article-title":"Fixed ratio schedules of food presentation and stimulus shock termination: effects of d-amphetamine, morphine, and clozapine","volume":"70","author":"McKearney","year":"1980","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0091-3057(81)90262-8","article-title":"D-Amphetamine and phencyclidine alone and in combination: effects on fixed-ratio and interresponse-time-greater-than-t responding of rats","volume":"15","author":"Poling","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.jpet.2025.103657_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1749-6632.1956.tb49639.x","article-title":"Modification by drugs of performance on simple schedules of positive reinforcement","volume":"65","author":"Dews","year":"1956","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103657_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-3565(25)11935-6","article-title":"Studies on behavior. IV. Stimulant actions of methamphetamine","volume":"122","author":"Dews","year":"1958","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.jpet.2025.103657_bib53","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3928\/00485713-20081101-01","article-title":"Anxiety disorders with comorbid substance use disorders: diagnostic and treatment considerations","volume":"38","author":"Back","year":"2008","journal-title":"Psychiatr Ann"},{"issue":"3","key":"10.1016\/j.jpet.2025.103657_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/dar.12419","article-title":"Substance use disorders comorbid with mood and anxiety disorders in the Australian general population","volume":"36","author":"Prior","year":"2017","journal-title":"Drug Alcohol Rev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:18:13Z","timestamp":1777943893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022356525398708"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103657","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using a rich-lean transition procedure to evaluate putative antianxiety medications","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103657"}}